Discover why male breast cancer cases are rising, learn essential warning signs most men miss, and understand new treatment options that could save lives.

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with ...